U.S., Feb. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07390864) titled 'Ergometrine Versus Carbetocin to Decrease Blood Loss in Myomectomy' on Jan. 17.
Brief Summary: The goal of this randomized clinical trial is to determine whether intramyometrial ergometrine injection or intramyometrial carbetocin injection is more effective in reducing blood loss during and after abdominal myomectomy in women undergoing surgery for symptomatic uterine fibroids.
The main questions it aims to answer are:
Does intramyometrial ergometrine reduce intraoperative and postoperative blood loss during abdominal myomectomy?
Does intramyometrial carbetocin reduce intraoperative and postoperative blood loss during abdominal my...